Cryo-Cell International, Inc. (CCEL)
NYSEAMERICAN: CCEL · Real-Time Price · USD
3.470
-0.610 (-14.95%)
Apr 28, 2026, 4:00 PM EDT - Market closed

Cryo-Cell International Stock Forecast

Stock Price Forecast

There is currently no analyst price target forecast available for Cryo-Cell International.

Analyst Consensus: Hold
Target Low Average Median High
Price n/a n/a n/a n/a
Change n/a n/a n/a n/a

Analyst Ratings

According to 1 stock analyst, the rating for Cryo-Cell International is "Hold". This means that the analyst believes this stock is likely to perform similarly to the overall market.

Recommendation Trends

Rating Jan '26Feb '26Mar '26Apr '26
Strong Buy 0000
Buy 0000
Hold 1111
Sell 0000
Strong Sell 0000
Total 1111

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Maxim Group
Maxim Group
Hold
Downgrades
n/a
Hold Downgrades n/a n/a Oct 20, 2025
Maxim Group
Maxim Group
Strong Buy
Maintains
$9$8.5
Strong Buy Maintains $9$8.5 +144.96% Mar 4, 2025
Maxim Group
Maxim Group
Strong Buy
Initiates
$12
Strong Buy Initiates $12 +245.82% Aug 29, 2022
More Analyst Ratings

Financial Forecast

Revenue This Year
30.95M
from 31.57M
Decreased by -1.97%
Revenue Next Year
n/a
from 30.95M
EPS This Year
0.07
from -0.30
EPS Next Year
n/a
from 0.07
Fiscal Year FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026
Period Ending Nov 30, 2021 Nov 30, 2022 Nov 30, 2023 Nov 30, 2024 Nov 30, 2025 Nov 30, 2026
Revenue
28.88M30.34M31.34M31.99M31.57M30.95M
Revenue Growth
-7.26%5.03%3.32%2.05%-1.31%-1.97%
EPS
0.250.33-1.140.05-0.300.07
EPS Growth
-44.44%30.95%----
Forward PE
-----48.60
No. Analysts -----3
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 2026
High 31.9M
Avg 30.9M
Low 29.7M

Revenue Growth

Revenue Growth 2026
High
0.9%
Avg
-2.0%
Low
-5.8%

EPS Forecast

EPS 2026
High 0.07
Avg 0.07
Low 0.07

EPS Growth

EPS Growth 2026
High -
Avg -
Low -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.